Citicoline Concentration in Human Vitreous

NACompletedINTERVENTIONAL
Enrollment

26

Participants

Timeline

Start Date

March 21, 2018

Primary Completion Date

January 31, 2019

Study Completion Date

January 31, 2019

Conditions
Neurodegenerative Diseases
Interventions
DRUG

Citicoline

After treatment with a solution containing citicoline 1% eye-drops, 0.2% high molecular weight hyaluronic acid and 0.01% benzalkonium chloride patients underwent a 23G standard 3-port pars plana vitrectomy. The vitreous sample was taken at the beginning of the surgery and then analyzed.

Trial Locations (1)

00198

Fondazione G.B. Bietti- IRCCS, Roma

All Listed Sponsors
collaborator

Fondazione G.B. Bietti, IRCCS

OTHER

lead

Istituto di Ricerca Neuroftalmologia S.r.l.

NETWORK

NCT04003090 - Citicoline Concentration in Human Vitreous | Biotech Hunter | Biotech Hunter